Skip to content

Status of digestion in non alcoholic fatty liver disease and the therapeutic effect of chitrakapippali ghrita.

An observational study to assess the status of agni in yakrita vikara (nafld) and the upashayatmak effect of chitrakapippali ghrita- single arm open label study.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051431
Enrollment
106
Registered
2023-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

ALL INDIA INSTITUTE OF AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: GRADE I and II NAFLD

Exclusion criteria

Exclusion criteria: Patients suffering from diabetic Mellitus, dyslipidemia, hypothyroidism, IBS, joint disorders, CAD, TB, and carcinoma Patients having Grade III NAFLD and any other liver disease Patients on medication for non-alcoholic fatty liver disease during last 3 months. Lactating and pregnant women.

Design outcomes

Primary

MeasureTime frame
Status of agni as assessed through CCRAS agni assessment questionnaire.Timepoint: Status of agni will be assessed at 1st,15th,30th,46th day of intervention.

Secondary

MeasureTime frame
Changes in USG finding.Timepoint: Changes in USG findings will be assessed at 1st and 46th day.

Countries

India

Contacts

Public ContactDr Sandeep Singh Tiwari

AII India Institute of Ayurveda

rashmisweet835@gmail.com9560138479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026